Rhumbline Advisers Catabasis Pharmaceuticals, Inc. Transaction History

Rhumbline Advisers

  • $113 Billion
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
N/A
-21,143 Closed
0 $0
Q4 2020

Feb 10, 2021
BUY
N/A
7,563 Added 55.69%
21,143 $45,000
Q3 2020

Nov 12, 2020
SELL
N/A
-2,135 Reduced 13.59%
13,580 $84,000
Q2 2020

Aug 13, 2020
BUY
N/A
15,715 New
15,715 $101,000

About Catabasis Pharmaceuticals, Inc.

CATB Quotes by TradingView
  • Ticker CATB
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,948,800
  • Market Cap $657M
More about CATB
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email